Drug Science Announce a 20,000 Patient UK National Medical Cannabis Pilot
the Pilot will be targeting the following patients and situations, specifically focusing on times in which alternative treatment has failed
IACM 2nd Conference on Cannabinoids in Medicine
The International Association for Cannabis as Medicine 2nd Conference on Cannabinoids in Medicine focused on new clinical research with cannabis and single cannabinoids (Delta(9)-tetrahydrocannabinol, CT-3) and on animal research with possible therapeutic implications. The meeting brought together basic researchers, clinicians and physicians to facilitate an exchange of knowledge and experience in this field.
Home Office revokes hemp growing license from leading UK grower
Hempen said it was being unfairly penalised and would appeal and is seeking legal advice
A List Cannabis Activist with a Hollywood Story by Che Capri
My therapist rolled a joint for me and had to show me how to smoke it, but after three puffs something happened. I started laughing.”
Patients in Thailand should see cannabis oil in August
Both the Food and Drug Administration and Medical Department will oversee distribution
A Life less ordinary by PSY-23
Every aspect of Red Eye Express was down to Nick, but throughout his life he was more commonly known by a pseudonym which has become the stuff of legend in the underground cannabis scene: Zorro.
Patient Profile – Eric Loyd- A better state of mind in the state of Maine by Sharon Letts
Greener Pastures Recovery boasts 99 percent success rate
History of cannabis and its preparations in saga, science, and sobriquet
Cannabis sativa L. is possibly one of the oldest plants cultivated by man, but has remained a source of controversy throughout its history. Whether pariah or panacea, this most versatile botanical has provided a mirror to medicine and has pointed the way in the last two decades toward a host of medical challenges from analgesia to weight loss through the discovery of its myriad biochemical attributes and the endocannabinoid system wherein many of its components operate.
Legislature agrees to fund study of marijuana efficacy
California could be the first State to conduct a research study on medical uses for marijuana under the “Medical Research Act of 1999”. S.B. 847 would authorize a three-year program, administered by the University of California, to study which methods of ingesting marijuana are most effective in treating pain and side effects of treatments for AIDS, cancer, glaucoma and seizures.
Cannabis-related cognitive impairment: a prospective evaluation of possible influences on patients with cancer during chemotherapy treatment as a pilot study
In patients with cancer, the use of medical cannabis has increased significantly during the recent years. There is evidence that cannabis consumption may affect cognitive performance; however, this potential effect has not been investigated prospectively in patients with cancer to date. We aimed to evaluate the effect of cannabis consumption on cognitive abilities as well as on symptom relief in patients with cancer during chemotherapy treatment. These preliminary findings suggest that the short-term use of cannabis during chemotherapy treatment improved disease-related symptoms and did not affect cognitive skills in patients with cancer.
